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Abstract 
Background: The number of annual total knee arthroplasties (TKA) had doubled over the last 
decade. Although this procedure treated chronic pain and restored mobility from end-stage 
osteoarthritis and other etiologies, it was associated with acute moderate-to-severe pain in the 
early postoperative period. Various analgesic techniques such as local infiltration, neuraxial 
blocks, and peripheral nerve blocks (PNB) were used in conjunction with multimodal anesthesia 
to prevent postoperative pain following TKA. The large variety of analgesic regimens 
accompanied with differing institutional and provider preferences challenged the ability to 
standardize a postoperative analgesic technique for TKA.  
Local Problem: Anesthesia providers at the project site often utilized the adductor canal block 
(ACB) alone or combined ACB and popliteal sciatic nerve block (PSNB) techniques for 
postoperative analgesia following TKA. However, it was unclear which technique was superior. 
Purpose: To understand the analgesic efficacy between ACB and combined ACB/PSNB 
following TKA.  
Methods: A retrospective chart analysis on 100 subjects that received ACB alone or ACB/PSNB 
for TKA in 2019. Pain was assessed upon post anesthesia recovery unit (PACU) admission, at 12 
hours, and at 24 hours. Total opioid consumption was recorded for the first 24 hours. Length of 
hospitalization (LOH) was recorded per documentation. 
Results: Pain during PACU stay, pain at 12 hours postoperatively, and opioid consumption at 12 
hours postoperatively were all significantly lower in the combined ACB/PSNB group (P = 
0.0182, 0.0488, 0.0106 respectively). Pain and opioid consumption at 24 hours and LOH were 
not significantly different between the two groups. 
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Conclusion: Combined ACB/PSNB therapy decreased pain and opioid consumption in the first 
12 hours postoperatively following TKA. Large randomized controlled trials (RCT) need to be 
performed to deem the efficacy and incidence of related complications between these two blocks.  
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Analgesic Efficacy for Total Knee Arthroplasty 
Introduction 
Total knee arthroplasty (TKA) was a commonly performed procedure that relieved joint 
pain and enhanced mobility in the patient with end-stage osteoarthritis and other degenerative 
etiologies (Li, Ma, & Xiao, 2019). Although this curable procedure often improved quality of life 
in the long-term, it was knowingly associated with acute moderate-to-severe pain within the first 
one to three postoperative days (Li, Ma, & Xiao, 2019). As modern medicine shifted focus to 
multimodal techniques, anesthesia providers sought after approaches to decrease postoperative 
complications and enhance recovery (Moucha, Weiser, & Levin, 2016). These regimens were 
often combined with multimodal anesthetics that included neuraxial anesthesia (e.g. spinal 
blockade), peripheral nerve blocks (PNB), periarticular injections, and non-opioid analgesics 
(e.g. ketamine or clonidine) (Moucha, Weiser, & Levin, 2016). Multimodal techniques 
incorporated various pharmacologic and interventional strategies to achieve optimal anesthetic 
and analgesic outcomes (Gaffney et al., 2017). Ideally, a balanced multimodal approach targeted 
postoperative pain, prevented significant changes in hemodynamic stability, allowed for early 
ambulation and mobility, decreased cost, avoided high-dose opioid consumption, and improved 
overall patient satisfaction (Li, Ma, & Xiao, 2019). As a result, PNBs that spared motor blockade 
(i.e. allow for ambulation) such as the adductor canal block (ACB) were becoming increasingly 
popular for lower extremity surgeries such as TKA. However, some studies argued that patients 
reported posterior and/or lateral pain knee pain when the ACB was used alone for TKA (Nader et 
al., 2016; Seo et al., 2017). Subsequently, different approaches to block the lower leg and knee, 
such as the popliteal sciatic nerve block (PSNB), were used in conjunction with the ACB to 
provide complete coverage (Seo et al., 2017). This project was conducted to determine the 
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postoperative analgesic effectiveness between two PNB regimens for patients that underwent 
TKA including ACB alone and combined ACB/PSNB.  
Background 
More than 700,000 TKAs were performed annually in the United States, making it one of 
the most common orthopedic procedures (Terkawi et al., 2017). In fact, the number of annual 
TKAs had doubled over the past decade (Abdallah et al., 2016). Osteoarthritis (OA), the number 
one indication for TKA, effected nearly 27 million people in the United States (Gaffney et al., 
2017). As a result, it was estimated that there would be a demand for nearly 3.5 million annual 
TKAs by 2030 (Terkawi et al., 2017). Severe postoperative pain remained a major concern for 
patients that underwent TKA. In fact, some patients refused or delayed arthroplasty because of 
reported acute postoperative pain (Gaffney et al., 2017). Although many people had chronic pain 
relief following TKA, some reported postoperative pain so severe that they would not repeat the 
surgery again if it were necessary for chronic relief (Gaffney et al., 2017). The goal of TKA was 
to diminish chronic pain from OA, yet severe acute postoperative pain was associated with 
chronic post-surgical pain that persisted for longer than six months (Moucha, Weiser, & Levin, 
2016; Terkawi et al., 2017).  
Adequate pain relief was essential for optimal patient satisfaction, rehabilitation 
following surgery, and physiologic function (Gaffney et al., 2017). There were countless adverse 
physiologic outcomes associated with uncontrolled pain including cognitive dysfunction, 
decreased immune function, anxiety, thromboembolism, decreased mobility, insomnia, 
vasoconstriction leading to end-organ damage, and pneumonia (Gaffney et al., 2017). 
Subsequently, patients were unable to participate in rehabilitation, and this led to prolonged 
hospitalization and increased cost of care (Gaffney et al., 2017). 
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Patients that experienced intense postoperative pain usually required high doses of opioid 
analgesics for relief (Gaffney et al., 2017). Opioids knowingly provided adequate pain relief as 
well as enhanced sleep and mood after surgery (Gaffney et al., 2017). Nonetheless, high dose 
opioids often produced undesirable adverse effects that consequently decreased patient 
satisfaction (Gaffney et al., 2017). These included pruritis, constipation, urinary retention, 
respiratory depression, nausea and vomiting, and reduced cognition (Gaffney et al., 2017; 
Moucha, Weiser, & Levin, 2016). These accompanied with the nation’s opioid epidemic led 
providers to favor balanced multimodal analgesia with minimal need for rescue opioids in the 
postoperative setting (Gaffney et al., 2017). 
There were more than ten multimodal techniques for postoperative TKA pain at the time 
of this project (Terkawi et al., 2017). Historically, femoral nerve blockade (FNB) was widely 
accepted as the gold standard for postoperative analgesia following TKA (Kuang et al., 2017; 
Zhang, Wang, & Liu, 2019). While FNB improved postoperative pain scores and decreased 
acute opioid consumption, it was also associated with other, less favorable outcomes such as 
impaired postoperative mobility (Kuang et al., 2017; Zhang, Wang, & Liu, 2019). While FNB 
may have spared motor blockade in low concentrations, it often resulted in complete anesthesia, 
both motor and sensory, to the anterior and medial thigh, knee, lower leg, and foot (NYSORA, 
2019). Decreased quadriceps strength delayed postoperative rehabilitation and mobility, 
prolonged recovery, and lengthened hospitalization (Kuang et al., 2017; Zhang, Wang, & Liu, 
2019). In addition, FNB was associated with postoperative falls, increased thromboembolism 
risk, and inadvertent blood vessel and nerve damage (Li, Ma, & Xiao, 2019). 
In recent years, the ACB had become a favorable alternative to the FNB. Studies reported 
ACB to be equal in analgesic effects with minimal effects on quadriceps muscle strength when 
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compared to FNB (Gao, et al., 2017; Zhang, Wang, & Liu, 2019). The ACB mainly anesthetized 
the saphenous nerve, the largest sensory branch of the femoral nerve, that supplied sensory 
innervation to the anteromedial knee, lower leg, and ankle (NYSORA, 2019). It also included 
articular branches of the obturator nerve and the knee joint (Kuang et al., 2017). These nerves 
traveled within a triangular-shaped canal of muscles in the distal anteromedial thigh (NYSORA, 
2019). Of note, while the ACB was considered a sensory-only block, it had been shown to cause 
quadriceps motor weakness with large local anesthetic volumes from inadvertent blockade of the 
nerve that supplied the vastus medialis (NYSORA, 2019). Nonetheless, when compared to the 
historical FNB, ACB was shown to provide equianalgesic properties with better functional 
recovery following TKA (Kuang et al., 2017). 
The utilization of the ACB shifted common multimodal analgesic techniques away from 
the use of FNB; however, some studies argued that both ACB and FNB resulted in residual 
posterior knee pain (Abdallah et al., 2016; Nader et al., 2016; Zorrilla-Vaca & Li, 2018). As a 
result, providers often used supplemental sciatic nerve blocks (SNB) that were shown to 
significantly reduce posterior knee pain and opioid consumption following TKA (Abdallah et al., 
2016; Seo et al., 2017; Terkawi, 2017). There were proximal and distal techniques to blocking 
the sciatic nerve; however, the distal popliteal SNB approach spared the hamstring motor nerves 
while anesthetizing the posterolateral aspect of the knee joint (Abdallah, 2014). It was also 
associated with easier administration and more comfortable positioning than the 
proximal/infragluteal approach (Abdallah, 2014). Like the FNB, the PSNB may have spared 
motor blockade in low concentrations, but it often resulted in complete motor and sensory 
blockade of the lower leg and foot, excluding the anteromedial sensory innervation from the 
saphenous nerve (NYSROA, 2019).  
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Although modern techniques improved patient safety, PNBs were associated with 
unfavorable side effects and adverse events. A major concern for a SNB was the risk for 
transient dorsiflexion impairment (i.e. foot drop) from blocking the common peroneal nerve, a 
major branch of the sciatic nerve (Seo et al., 2017). Dorsiflexion impairment was associated with 
an increased risk for postoperative falls (Gaffney et al, 2017; Seo et al., 2017). When blocking 
the sciatic nerve, it was common for anesthesia providers to discuss the possibility of foot drop 
and/or lower extremity weakness with patients in the preoperative setting to avoid postoperative 
falls. Additionally, some surgeons were concerned that foot drop masked surgical peroneal nerve 
injury, but surgical nerve palsy usually persisted beyond the 24 hours of foot drop seen with 
PSNB (Seo et al., 2017). Nonetheless, some surgeons still advised against blocking the sciatic 
nerve for TKA related to dorsiflexion impairment. 
The use of ultrasonography (US) allowed experienced providers to visualize real-time 
spread of local anesthetic, reducing the rate of failed block, intraneural injection, or intravascular 
injection (NYSORA, 2019). Additionally, electrical peripheral nerve stimulation was often used 
for motor-blocking techniques such as the PSNB (NYSORA, 2019). Nerve stimulation allowed 
experienced providers to locate and anesthetize peripheral nerves or plexuses with or without the 
use of US-guidance (NYSORA, 2019).  
To promote Enhanced Recovery After Surgery (ERAS) protocols, anesthesia providers at 
the project site commonly used two different multimodal PNB approaches to target pain 
following TKA. For the orthopedic surgical patient, ERAS protocols focused on postoperative 
analgesia, ambulation, and decreased hospitalization for rapid recovery (Oseka & Pecka, 2018). 
The increased risk for falls and decreased motor strength associated with FNB favored the use of 
the ACB for postoperative TKA analgesia (Kuang et al., 2017; Zhang, Wang, & Liu, 2019). 
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Although FNB was still utilized at the project site, ACBs were more commonly used. 
Additionally, some anesthesia providers supplemented the ACB with a PSNB to target the 
posterior portion of the knee and knee joint.  
Problem Statement 
 Inadequate pain relief in the acute postoperative setting remained a major focus for the 
patient that underwent TKA. Utilizing the most effective multimodal analgesic technique would 
have diminished postoperative complications related to uncontrolled pain, decreased length of 
hospitalization (LOH), improved patient satisfaction, decreased opioid consumption, and reduced 
cost of care. Knowing the efficacy between two common modalities used at the project site, 
ACB alone and ACB/PSNB combination therapy, would have ensured staff and patients that 
optimal analgesia was obtained while using minimal resources, expenses, and procedure times.  
To address the efficacy between postoperative peripheral nerve block analgesia, the following 
PICOT question was created: 
For adult patients undergoing TKA, is single-shot ACB and PSNB combination therapy 
more effective at reducing pain in the first 24 hours postoperatively compared to single-
shot ACB alone?   
 To deliver the most effective evidence-based care, this quality improvement project 
explored the efficacy between these two PNBs. This project retrospectively analyzed pain scores 
and total opioid consumption within the first 24 hours postoperatively on adult patients that 
underwent TKA. Once statistical analysis was completed, the DNP student reported findings to 
the anesthesia department at the project site to deem significance and the need for clinical 
practice adjustments.  
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Organizational “Gap” Analysis of Project Site  
 The discussed clinical gap at the project site was identified by the Section Chief of the 
Department of Anesthesiology and Medical Director of Surgical Services. Using guidelines set 
by the Agency for Healthcare Research and Quality (AHRQ, 2016), a gap analysis was 
performed to guide the discussed DNP project. There was not a standardized protocol for 
multimodal analgesia or anesthesia for TKA patients at the time of this project. However, most 
patients underwent general anesthesia with muscle relaxation and received a PNB for 
postoperative analgesia. This technique was determined by length of surgery (often exceeding 
two hours), surgeon preference, anesthesia provider preference, and patient factors. While each 
anesthetic plan was individualized, the decision about PNB lied in the collaborative hands of the 
surgeon and assigned anesthesia provider. Some surgeons requested that the sciatic nerve was 
not blocked with fear of dorsiflexion impairment.  
The anesthesia providers at the project site were unsure whether supplementally blocking 
the sciatic nerve was necessary for complete postoperative analgesia following TKA. They did 
not regularly follow uncomplicated post-surgical TKA patients throughout their hospitalization, 
so it was difficult for them to accurately assess long-term PNB efficacy. Subsequently, in 
collaboration with project site and Marian University staff, the DNP student proposed this 
quality improvement project to determine whether combined ACB/PSNB therapy was a more 
significant postoperative analgesic regimen when compared to ACB alone for the TKA patient. 
Review of the Literature 
Search Strategy 
 Review of supportive literature was performed after a specific problem statement was 
created. The DNP student searched electronic databases including PubMed, Cochrane Library, 
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and Google Scholar from 2015-2020 without language limitation or region exclusions. Results 
were filtered to include only clinical trials, systematic reviews, and meta-analyses. A total of 79 
articles were included after excluding duplicates. Twenty-one results were found using keywords 
“adductor canal block,” “sciatic nerve block,” and “knee.” Three of these articles were included 
based on relevance and abstract review. A second search resulted in 58 results using keywords 
“femoral nerve block,” “sciatic nerve block,” and “total knee arthroplasty.” Two of these articles 
were included after excluding studies that did not directly discuss SNB as a complement to FNB 
in TKA patients. This literature review included a total of 7 peer-reviewed research articles. 
ACB alone versus combined ACB/SNB Therapy 
 Postoperative analgesic efficacy comparing ACB to ACB/PSNB combination therapy for 
TKA was published in a peer-reviewed article in 2017 (Seo et al., 2017). This retrospective study 
performed in 2015-16 evaluated 200 patients that underwent TKA by evaluating pain, opioid 
consumption and associated complications following each technique (Seo et al., 2017). Patients 
received continuous ACB catheters in addition to placebo (group A) or local anesthetic (group B) 
injections for PSNB (Seo et al., 2017). All blocks were performed with US-guidance prior to 
subarachnoid (i.e. spinal) blockade by the same anesthesiologist, and the TKA was performed by 
the same surgeon (Seo et al., 2017). Outcomes were measured in intervals over seven 
postoperative days (POD), and statistical analysis considered significant p-values < 0.05 (Seo et 
al., 2017). Pain at rest, pain with knee flexion, and PCA requirements were all significantly 
lower in group B (combined ACB/PSNB therapy) (Seo et al., 2017). The authors stated that 
posterior knee pain appeared to be the main region of pain relief in those that received PSNB 
compared to those that received placebo (Seo et al., 2017). Although this study revealed superior 
analgesic effects using combined ACB/PSNB therapy, 35% (n = 35) that received PSNB 
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experienced transient foot drop (Seo et al., 2017). This finding warranted the need for further 
research into the technique for adequately blocking the sciatic nerve using the popliteal approach 
(Seo et al., 2017).  
 A randomized control trial (RCT) and a retrospective trial were published in 2016 
comparing ACB and FNB in the presence of a SNB for patients that underwent TKA (Ardon et 
al., 2016, Wiesman et al., 2016). The goal of both trials was to determine if it was necessary to 
block the posterior aspect of the thigh and popliteal fossa using the FNB (Ardon et al., 2016; 
Wiesman et al., 2016). In other words, investigators wanted to know if dorsal innervation from 
the FNB was superior to dorsal innervation from combined ACB/SNB (Ardon et al., 2016, 
Wiesman et al., 2016). Like the study by Seo et al. (2017), these trials evaluated postoperative 
pain, analgesic consumption, and associated complications for two and three PODs (Ardon et al., 
2016; Wiesman et al., 2016). All blocks were performed using US-guidance (motor blocks also 
utilized nerve stimulators) prior to induction of general anesthesia, although some participants 
from the retrospective study received spinal anesthesia instead of general (Ardon et al., 2016, 
Wiesman et al., 2016). All patients and providers were blinded in the RCT (Wiesman et al., 
2016). Both trials considered statistically significant p-values of < 0.05 (Ardon et al., 2016; 
Wiesman et al., 2016).  
The findings from these two studies reported no significant differences between ACB and 
FNB in the presence of SNB regarding overall analgesic effect, opioid consumption, or other 
associated complications (Ardon et al., 2016; Wiesmann et al., 2016). The only significant 
difference included anterior knee pain during motion on POD 1 (P = 0.002) that was significantly 
higher for one of the ACB/SNB groups (Ardon et al., 2016). However, median pain scores never 
exceeded 4/10; therefore, the authors still concluded equianalgesic effects between the groups 
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(Ardon et al., 2016). Additionally, two patients that received FNB experienced falls (Wiesman et 
al., 2016). In summary, when evaluating pain, opioid consumption, and other related 
complications, these two studies suggested ACB to be an equal and maybe even a favorable 
alternative to FNB in the presence of SNB (Ardon et al., 2016; Wiesman et al., 2016).  
 Another double blinded RCT published in 2016 used a placebo group to determine the 
analgesic efficacy of ACB following TKA (Nader et al., 2016). Forty patients received 
preoperative US-guided ACB (group A, n = 20) or saline (Group B, n = 20) in addition to 
periarticular infiltration and spinal anesthesia (Nader et al., 2016). Pain and opioid consumption 
were recorded for 36 hours postoperatively, and statistical analysis considered significant p-
values < 0.05 (Nader et al., 2016). Although generalizability from this study was limited by a 
small sample size, results strongly supported the use of ACB over placebo (Nader et al., 2016). 
Opioid consumption (P = 0.03) and pain (P = 0.009) were both significantly lower in the first 36 
hours in the ACB group (Nader et al., 2016). Time to discharge was also significantly lower in 
the ACB group (P = 0.007) (Nader et al., 2016). Of note, many of the patients in the ACB group 
reported posterior knee pain as the primary location of perceived pain (Nader et al., 2016).  
Supplementing FNB with SNB 
 At the time of this project, there was not a published systematic review or meta-analysis 
directly evaluating the analgesic efficacy between ACB alone versus ACB/PSNB for TKA. This 
could have been in part because of the wide array of TKA analgesic modalities or because the 
ACB was a relatively new block. However, there were published peer-reviewed articles that 
reported superior analgesia when supplementing FNB with SNB to target residual dorsal knee 
pain (Abdallah et al., 2016; Zorrilla-Vaca & Li, 2018). These studies supported the need for 
ANALGESIC EFFICACY FOR TKA   16 
 
complementary posterior knee blockade for adequate postoperative TKA analgesia (Abdallah et 
al., 2016; Zorrilla-Vaca & Li, 2018). 
Two meta-analyses aimed to determine if blocking the sciatic nerve resulted in superior 
postoperative TKA analgesia in the presence FNB (Abdallah et al., 2016; Zorrilla-Vaca & Li, 
2018). Both studies reviewed pain, opioid consumption, and recovery outcomes in adult patients 
that underwent TKA (Abdallah et al., 2016; Zorrilla-Vaca & Li, 2018). Abdallah et al. (2016) 
reviewed 8 RCTs (n = 379), and Zorrilla-Vaca & Li (2018) reviewed 10 RCTs (n = 514). In the 
postoperative period, Zorrilla-Vaca and Li (2018) reported reduced pain at rest for 4 hours (P < 
0.001) and reduced pain with activity for 12 hours (P = 0.02) when using a single-shot SNB in 
the presence of FNB. Abdallah et al. (2016) reported decreased pain at rest and activity for 8 
hours using supplemental single-shot SNB (P = 0.023 and P < 0.001) and with activity for 36 and 
48 hours using supplemental continuous SNB (P = 0.004 and P = 0.031). Both studies reported 
decreased opioid consumption for 24 hours postoperatively (Abdallah et al., 2016; Zorrilla-Vaca 
& Li, 2018). Although there was a gap in evidence supporting duration of analgesic efficacy, 
these meta-analyses concluded that SNB significantly reduced postoperative TKA pain when 
compared to no SNB in the presence of FNB (Abdallah et al., 2016; Zorrilla-Vaca & Li, 2018).  
Evidence Based Practice 
 Numerous analgesic regimens have been known to control postoperative TKA pain. The 
variety of modalities challenged the ability to perform a single RCT using every analgesic 
technique. Each study in the literature review was limited by differing patient anatomical nerve 
innervation, approach to blockade, surgical technique, extraneous and confounding variables, 
and selection of local anesthetic. These variables limited appropriate evaluation of PNB efficacy. 
Additionally, some available literature included variables that were not included in this project, 
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including continuous PNB catheters, subarachnoid blockade, patient-controlled analgesics, 
placebo groups, and control of local anesthetic and adjuncts. However, overall results from the 
discussed studies supported the need for posterior knee blockade for patients that underwent 
TKA. Furthermore, these studies supported ACB as a favorable alternative to FNB. This DNP 
project focused on the two primary outcomes assessed in the literature including pain and opioid 
consumption. The aim of evaluating length of hospitalization was to guide future studies 
comparing cost savings between the two blocks. The duration of block efficacy was assessed 
over the first 24 hours postoperatively, and the popliteal approach to block the sciatic nerve was 
assessed because it was the most common technique used at the project site. 
Evidence Based Practice Model 
The Johns Hopkins Nursing Evidence-Based Practice (JHNEBP) model is a conceptual 
framework utilized in nursing to ensure current evidence-based practice (EBP) is integrated into 
the clinical setting (Dang & Dearholt, 2017). See Appendix A for the model diagram. This 
conceptual model was the framework used for this DNP project as it focuses on the key idea that 
healthcare professionals are lifelong learners that provide the best quality and evidence-based 
care (Dang & Dearholt, 2017). This three-step model uses the acronym “PET” including a 
problem statement, review of current evidence and literature, and practice translation (Dang & 
Dearholt, 2017). First, a question was derived from exploring background information gathered 
by the key project members (Dang & Dearholt, 2017). The PICOT (population, intervention, 
comparison, outcome, time) format was used because it is a focused question that can be 
answered with current evidence-based research (JHM, 2018). Following creation of a problem 
statement, the DNP student performed a comprehensive literature review to collect current, 
pertinent, and high-quality evidence to support the given problem (Dang & Dearholt, 2017). 
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Project members then determined how applicable available evidence was to the specific 
population (Dang & Dearholt, 2017). This is where the discussed quality improvement (QI) 
project implementation and analysis occurred. Once available current literature and results from 
the QI project was analyzed, investigators determined that there was a need for clinical practice 
change at the project site.  
Cost-Benefit Analysis 
  The costs endured by this DNP project included the time for development, 
implementation, analysis, and proposed clinical practice change by the project members, 
university staff, and additional hospital staff that assisted the DNP student in implementation. 
The benefit of the review of literature and project findings largely outweighed the cost as it 
helped ensure patients were receiving the best quality and cost-effective PNB for TKA. 
Timeline 
Proposed approval of this project was given to the DNP student by university staff on 
October 11, 2019, and a final PICOT question was approved three days later. Literature review 
was performed over the next two months and included an annotated bibliography, matrix review, 
and SWOT analysis. A final project proposal was submitted December 2019. Project site 
approval and Marian University IRB exemption was given in February 2020. Following 
approval, the DNP student collaboratively discussed the need for remote Cerner access with the 
Department of Volunteer Services, and access was granted in April 2020. Data collection and 
analysis was performed over the summer of 2020. Project findings were presented to Marian 
University and staff at the project site as a finalized DNP project in October 2020. 
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Goals, Objectives, and Expected Outcomes 
 The overall aim of this DNP project was to determine which PNB, either ACB alone or 
ACB/PSNB combination therapy, was more effective at decreasing postoperative pain, opioid 
consumption, and LOH following TKA. A retrospective chart review was performed to 
determine pain scores, opioid consumption, and LOH among adult patients that received these 
multimodal approaches prior to unilateral TKA. The DNP student performed all data extraction 
and analysis, and she reported the findings to the anesthesia providers at the project site and 
accompanied staff at Marian University.  
Ethical Considerations/Protection of Human Subjects 
 The Marian University IRB deemed this DNP project exempt from review—See 
Appendix C. Exempt status was given because this project offered minimal risk to participants, 
analyzed existing data, and did not have an interventional group. The DNP student also 
completed online CITI training for research involving human subjects prior to project initiation. 
All participants included in this project were protected by the Health Insurance Portability and 
Accountability Act of 1996 (HIPAA). Furthermore, the DNP student and other personnel 
involved in this project followed the Standards of Care for practice at Marian University. All 
patient data was immediately de-identified and stored electronically on the DNP students’ 
personal laptop. This laptop and Cerner, the EMR used for chart analysis, were password 
protected to prevent access by unauthorized users.  
Project Design 
The comparative groups in this DNP project included ACB alone (group A) and 
ACB/PSNB combination therapy (group B). Both groups included adult patients that underwent 
unilateral TKA. All data was retrieved via retrospective chart analysis. 
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Project Site  
The project site was a rural, Magnet, Level III Trauma Center. This hospital served 
approximately nine counties across the Midwest in Indiana and Illinois. Surgical services ranged 
from dental procedures to open-heart with a total of over 10,000 surgeries performed annually. 
Orthopedic services, including TKAs, were offered through the joint replacement center and 
program for sports injuries, joint replacement, and other bone anomalies. 
The anesthesia group that staffs the project site is a private group that employs Physician 
Anesthesiologists and Certified Registered Nurse Anesthetists (CRNA) to collaboratively care 
for surgical patients. The Section Chief of the Department of Anesthesiology and Medical 
Director of Surgical Services at the project site acted as the liaison for the DNP student 
throughout this project. Additional project support came from the DNP students’ program staff. 
Success of this QI project relied largely on chart reviews performed on patients that 
underwent TKA in the operating room (OR) at the project site. Although there was a pain 
assessment protocol for each patient encounter, nursing documentation between nurses was 
highly variable, especially following PACU discharge. The inconsistency in charting resulted in 
repeated and missing values, and the DNP student had to adjust outcome intervals accordingly. 
As a result, pain and opioid consumption were recorded at a time point instead of cumulatively 
over a time interval following PACU discharge. Although evaluating cumulative data would 
have likely been more accurate, the inconsistency in charting prevented the ability to do this. 
Subject Population 
Subjects included adult patients that underwent primary, unilateral TKA at the project 
site between January 2019 and April 2019. Inclusion criteria for participants consisted of adult 
patients over eighteen that underwent unilateral TKA with a general anesthetic and preoperative 
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ACB or combined ACB/PSNB. Participants were excluded if they were unable to understand the 
numeric rating scale, classified as American Society of Anesthesiologists (ASA) IV or V, 
received contralateral or revised TKA within three months of the current surgery, received 
additional or rescue PNBs, or underwent alternative anesthetic methods (e.g. spinal anesthesia). 
Additionally, there were two subjects that were excluded because they experienced severe 
postoperative complications unrelated to the PNB. 
Methods 
This project included a retrospective, non-randomized design using a convenience sample 
to determine the analgesic efficacy of PNB for postoperative TKA analgesia.  
Procedures 
 All subjects underwent primary, unilateral TKA by different surgeons using a medial 
parapatellar approach. Following a collaborative decision with the surgeon, anesthesia providers 
performed all ACBs and PSNBs prior to induction of general anesthesia. ACBs were performed 
with US-guidance, and PSNBs were performed with US-guidance, peripheral nerve stimulation, 
or both.  
All outcome data was recorded separately from the subject’s medical record on the DNP 
student’s data collection form. This data form was pre-authorized by Marian University staff, 
and it was coded to exclude all protected health information. Chart reviews were performed 
through remote access using Cerner, the electronic medical record (EMR) system utilized at the 
project site. Collection of demographic information included patient age, ASA, and gender. 
Outcome variables including postoperative pain scores, opioid requirements, and LOH were 
recorded to determine which block was more effective at decreasing postoperative pain in the 
first 24 hours following TKA.  
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Measurement Instruments  
 Pain scores were recorded using an 11-point numeric rating scale (McCaffery & Pasero, 
1999). This was the main pain scale utilized at the project site for awake and responsive patients. 
The numeric rating scale allowed patients to verbally rate pain between 0 and 10, with 0 
representing no pain and 10 representing worst pain ever (McCaffery & Pasero, 1999). See 
Appendix B for scale.  
Opioid consumption was recorded based on drug, route and dose administered. Total 
opioid consumption was calculated using an opioid equianalgesic conversion calculator based on 
American Pain Society guidelines available at https://clincalc.com/Opioids/ (ClinCalc, LLC, 
2017). Each opioid was converted to intravenous (IV) morphine milligram equivalents (MME) 
with a 0% cross-tolerance for acute administration (ClinCalc, LLC, 2017). Outcomes were 
recorded for 24 hours postoperatively in two separate time intervals (t = 0-12 hours and t = 12-24 
hours). 
Data Collection Procedures  
The DNP student collected all data via retrospective chart analysis using convenience 
sampling. Data was recorded and de-identified on an excel data spreadsheet that was pre-
authorized by university staff. Time intervals were manually calculated and entered in Cerner 
based on the initial postoperative anesthesia care unit (PACU) time that was documented by the 
anesthesia provider. LOH was recorded as the length of stay documented in the patient’s chart.  
The pain assessment protocol at the project site in the PACU stated that an initial 
assessment must be recorded upon admission followed by an assessment every fifteen minutes 
until discharge. If the patient experienced analgesic changes between the fifteen-minute 
intervals, this pain score was also documented. All pain scores documented during the patient’s 
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PACU stay were recorded and presented as an average PACU pain score. Pain scores were also 
recorded at 12- and 24-hour points (t = 12 hours and t = 24 hours). If there was more than one 
score documented at a given time point, the average between the scores was recorded. If there 
was not a pain score documented for a time point, the average between the two most recent pain 
scores was recorded. One patient was discharged prior to twelve hours post-operatively, and no 
assumptions were made or included from this patient for data analysis at t = 12 or t = 24 hours.  
Total opioid consumption was recorded for 24 hours postoperatively in two separate time 
intervals (t = 0-12 hours and t = 12-24 hours) using the Medication Administration Record 
(MAR). Opioids included fentanyl, morphine, hydrocodone, hydromorphone, oxycodone, and 
tramadol. Each administered opioid was recorded based on route and dose, and then they were 
converted to intravenous MME. Total opioid consumption for each time interval was presented 
as total MME. Two patients received meperidine (Demerol) as an anti-shivering adjunct. 
Although meperidine was an opioid analgesic, these were not included in data analysis because 
they were not administered based on pain reported by the patient. 
Data Analysis  
 Sigma XL in Microsoft Excel 2016 was used to perform statistical analysis for this 
project. Comparisons between treatment groups were determined using the Mann-Whitney U test 
with a statistical significance of P < 0.05. 
Results 
Participants 
 Subjects included 100 patients who underwent primary, unilateral TKA. Groups included 
50 patients that received ACB (group A) and 50 patients that received combined ACB/PSNB 
(group B). Group A comprised of 28 female and 22 male subjects, with a mean age of 69.5. Of 
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the fifty subjects in group A, 18 were classified as ASA 2, and 32 were classified as ASA 3. 
Group B was comprised of 35 female and 15 male subjects with a mean age of 69.1. Of the fifty 
subjects in group B, 19 were classified as ASA 2, and 31 were classified as ASA 3. 
Pain Scores 
 The average PACU pain scores were significantly lower in group B than group A (P = 
0.0182). Pain at 12 hours postoperatively was also significantly lower in group B than group A 
(P = 0.488). There was no significant difference between pain at 24 hours postoperatively (P = 
0.2183).  
PAIN DURING PACU   
PNB ACB ACB/PSNB  
Count 50 50  
Median 2.944 1.1  
    
Mann-Whitney Statistic 2863.50   
P-Value (2-sided adjusted for ties) 0.0182   
    
    
PAIN @ 12 HOURS (t = 12) 
PNB ACB ACB/PSNB  
Count 49 50  
Median 2 1.500  
    
Mann-Whitney Statistic 2729.00   




PAIN @ 24 HOURS (t = 24) 
PNB ACB ACB/PSNB  
Count 49 50  
Median 3 2  
    
Mann-Whitney Statistic 2624.50   
P-Value (2-sided, adjusted for ties) 0.2183   
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Opioid Consumption 
 Opioid consumption over the first 12 hours postoperatively was significantly lower in 
group B than group A (P = 0.0106). There was not a significant difference between total opioid 
consumption from 12 to 24 hours postoperatively (P = 0.1784).  
TOTAL MME 0-12 HOURS 
  
PNB ACB ACB/PSNB  
Count 50 50  
Median 9.500 8  
    
Mann-Whitney Statistic 2895.00   
P-Value (2-sided, adjusted for ties) 0.0106   
 
TOTAL MME 12-24 HOURS  
PNB ACB ACB/PSNB  
Count 50 50  
Median 8 8  
    
Mann-Whitney Statistic 2718.00   
P-Value (2-sided, adjusted for ties) 0.1784   
 
Length of Hospitalization 
 There was no significant difference in LOH between the two groups (P = 0.8437). 
Length of Hospitalization (LOH)    
PNB ACB ACB/PSNB  
Count 50 50  
Median 2.400 2.400  
    
Mann-Whitney Statistic 2496.00   
P-Value (2-sided, adjusted for ties) 0.8437   
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Discussion 
 This study aimed to determine the efficacy of PSNB in the presence of ACB as a 
postoperative analgesic technique for TKA. Significant findings included decreased pain and 
opioid consumption for up to 12 hours postoperatively for combined ACB/PSNB techniques 
when compared to ACB alone. These findings suggested superior analgesic effects using 
combined ACB/PSNB for TKA when compared to ACB alone. There was no significance 
between the two PNBs after twelve hours postoperatively. Additionally, there was no 
significance in data for LOH between the two PNB techniques. The inability to control for 
confounding variables such as local anesthetic type, volume, adjuncts (e.g. dexamethasone, 
epinephrine, etc.), and subsequent duration of action created a major limitation for this 
retrospective project. Future projects should control for these variables. 
 As mentioned, the retrospective nature of this study presented several limitations. Large 
sample RCTs need to be performed to accommodate for these. RCTs would allow for control of 
inconsistent nursing documentation that prevented the DNP student from including all pain 
scores documented over the 24-hour time frame. Although total opioid consumption consistently 
reflected the pain scores for each time interval, this limitation likely created subsequent bias. 
Additionally, RCTs would allow accurate exclusion of participants that have underlying chronic 
pain syndromes or long-term opioid use that may affect pain and opioid consumption. Lastly, 
complications such as dorsiflexion impairment in the presence of PSNB and the impact it has on 
postoperative mobility should also be further evaluated. 
Conclusion 
 This project suggested that combined ACB/PSNB was a superior analgesic technique for 
the first 12 postoperative hours following TKA. Postoperative pain following TKA continues to 
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be a major focus for TKA patients, and inadequate analgesia results in poor postoperative 
outcomes. Comparative studies including randomized, blinded controlled trials need to be 
conducted to further determine analgesic efficacy, associated complications, and cost 
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